Data shows that vitamins, minerals and supplement sales in Australia recorded almost 70% growth since 2013, while multivitamins excluding minerals grew by 34% in 2017 alone. Complementary Medicines Australia’s health economist Aiden Essery explains why.
In its preliminary fiscal year end report, ChromaDex says its increased transaction revenue is ample compensation for heavy marketing expenditures and sharply higher losses.
Supplement firm GNC looks set for considerable expansion in China, with Harbin Pharmaceutical Group Holding Co (Hayao) investing $300m to become the firm's largest single shareholder.
Yakult Danone India, a 50:50 joint venture between Yakult Honsha and Danone, has released the latest variant on its signature probiotic drink, called Yakult Light.
Focusing too much on the innovation behind a new product and not grounding it in the benefits for the consumer is one of the main reasons why a high proportion of new supplement and functional food products fail to achieve sales success, according to...
Chinese investment into Australian health firms, including supplement manufacturers, will continue to grow as the country's healthcare system matures and the population ages, analysts from KPMG are forecasting.
NutraIngredients-Asia and FoodNavigator-Asia are bringing together business leaders, policymakers and academics to debate how industry can meet the food and nutritional challenges brought about by Asia-Pacific's rapidly ageing population.
A division of China's state-run investment fund is believed to be among the front runners to snap up Australian vitamin maker Nature's Care, as it embarks on its second sale attempt with a price tag of around $1bn.
Hemp mānuka honey will be on the shelves in Australia by the middle of the year, with the two companies behind the project then aiming for sales to China, the wider Asia region, and potentially North America and Europe.
A unique inhaler designed to be less cumbersome than the standard 200-dose puffers could be used to deliver nutrition through the lungs — with distinct uses in Asia.
African pharma and nutra giant Aspen Pharmacare can continue to sell its infant formula brand Alula in China, after it was registered by the China Food and Drug Administration (CFDA).
Herbalife has chosen South Korea for the launch of its new personalised nutrition programme, Gene Start, as it seeks to capitalise on growing APAC demand for customised health solutions.
Australian infant nutrition firm Wattle Health hopes to get its goat milk infant formula on the shelves in China by the second half of the year, after securing a 'brand slot' with a licensed manufacturer.
Danone has announced its intention to bow out of its dairy business in India, where it will then concentrate on enhancing its nutrition portfolio instead.
Asia-Pacific's functional food market for heart health products is being tipped to reach US$655.7m by the end of 2026, with sales increasing by 6.8% over the forecast period.
Australian biotechnology firm Marinova has achieved novel foods status in the EU for its Maritech® fucoidan extracts, and the firm is now targeting growth in the region's functional beverage and supplement sectors.
Singapore personalised nutrition firm Imagene Labs has sealed a deal with an Australian e-commerce venture, as it makes its first move into the country.
Australia's biggest hemp foods firm, which also has a cannabinoid (CBD) nutraceuticals and medical cannabis offering, launched today on the Australian Stock Exchange following a successful $20m IPO.
Australian supplements exports have more than doubled over the past three years, but the industry believes the sector can reach even greater heights with more government backing.
China’s new infant formula laws have finally come into force, 18 months after the proposals were unveiled sparking regulatory uncertainty, market volatility and a frantic dash to meet the more stringent regulatory requirements.
Personalised nutrition, regulation and industry growth were three of the hottest topics across our 2017 coverage of the Japan nutrition and supplements market.
Herbalife Nutrition has announced the latest appointment to its Nutrition Advisory Board (NAB), Thailand-based sports medicine expert Dr Korakod Panich.
Rule changes in China dominated the regulatory landscape for the supplement and infant nutrition industries in Asia over the past 12 months — and this was clearly reflected in our top five policy stories of 2017.
Fears that India's new GST framework could negatively impact health food and supplement businesses have been played down, with two firms telling us that July's rule changes haven't damaged business.
The Australian Federal Government will cut rebates for a range of natural therapies from 1 January 2019, affecting 16 widely used therapies such as naturopathy, herbal medicine, homeopathy, yoga, tai chi and aromatherapy, writes the president of the Australian...
Today, we can reveal the five most read trends stories for 2017, spanning the latest consumer and market insights from Japan, Thailand, China, and the wider region.
Kolkata-based healthcare start-up Kapiva Ayurveda is looking to expand across Asia and North America, with Hong Kong and Canada next on its list after its success in Singapore and the US.
Australian firms topped the list of our most read manufacturer stories for 2017, underlining the dominance of brands such as Blackmores and Swisse across Asia-Pacific.
Australian dairy manufacturer Burra Foods has announced an A$24.5m investment in a new infant formula blending and canning factory in Korumburra, South Gippsland, Victoria.
Australian contract manufacturer Vitex Pharmaceuticals has opened a new A$100m facility in Eastern Creek, Sydney, to better meet ever-growing global demand for Australian-made vitamins and supplements.
Singapore's consumers overwhelmingly favour global supplement and infant formula brands over local outfits, according to new research from Nielsen, though local food firms remain popular.
The traditional Chinese medicine industry grew by 20% in China in the past year, according to the State Administration of Traditional Chinese Medicine (SATCM).
UNICEF (United Nations Children’s Fund) Pakistan's nutrition chief Melanie Galvin has compared infant formula manufacturers to the tobacco industry, saying they have been "using similar tactics here after regulations were tightened against them...
Global manufacturers of speciality infant formulas have received a major boost from the Chinese government, which has done away completely with the 20% import duty.
Swisse Wellness' parent company, H&H (Health & Happiness) Group — formerly Biostime — has bought back the vitamin firm's distribution rights from PGT Healthcare for $131m, including those for the key China market.
Australian supplement firm Blackmores has entered Singapore's increasingly competitive infant formula market, albeit with a more cautious approach in light of recently enforced government regulations.
Indian supplier VAV Life Sciences is targeting sales growth for its Lipova egg yolk powders for supplements, functional foods, infant formula and sports nutrition products, after moving to a new GMP-certified facility earlier this year.
Probiotic supplier Ganden says its recent acquisition by Kerry Group will allow it to fast-track the growth of its products in Asia, with China and India having bene identified as two markets that are "impossible to ignore".
![Beauty consumers are most likely to prioritise devices and treatments as solution over supplements. [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/cosmetics/cosmeticsdesign-asia.com/headlines/market-trends/beauty-supplements-consumers-likely-to-explore-devices-treatments-before-supplements/17712040-1-eng-GB/Beauty-supplements-Consumers-likely-to-explore-devices-treatments-before-supplements.jpg)
